Mobius One Point

November 24, 2008

Lowering Blood Pressure In Elderly Using Audio Relaxation Program

Filed under: Uncategorized — Tags: , , , — poster @ 10:36 pm

An audio relaxation program lowered blood pressure more than a Mozart sonata in a group of elderly people with high blood pressure, researchers reported at the American Heart Association’s 62nd Annual Fall Conference of the Council for High Blood Pressure Research.
In a study of 41 elderly participants at three retirement facilities:
Twenty participants listened three (more…)

National Positive Thinking Trial Aims To Prevent Childhood Depression

Filed under: Uncategorized — Tags: — poster @ 9:35 pm

More than 7,000 school pupils from across the UK will be taking part in the trial of a new positive thinking programme led by the University of Bath designed to prevent children developing problems with depression.
Around one in ten children have symptoms which place them at high risk of becoming seriously depressed. If (more…)

Coating Improves Electrical Stimulation Therapy Used For Parkinson’s, Depression, Chronic Pain

Filed under: Uncategorized — Tags: — poster @ 9:35 pm

Researchers at UT Southwestern Medical Center have designed a way to improve electrical stimulation of nerves by outfitting electrodes with the latest in chemically engineered fashion: a coating of basic black, formed from carbon (more…)

Chronic Obstructive Pulmonary Disease (COPD) Often Associated With Other Illnesses

Filed under: Uncategorized — Tags: — poster @ 9:35 pm

This is according to an American study. Its authors recommend screening
for diabetes, arterial hypertension and cardiovascular disease in
patients with COPD.
The study, to be published in the forthcoming issue of the
European Respiratory Journal (ERJ), the scientific publication
of the European Respiratory Society, finds that chronic
obstructive pulmonary disease (COPD) is often associated
with other (more…)

Teva Introduces Nicardipine HCl Injection In The United States; First Alternative To Cardene(R) I.V.

Filed under: Uncategorized — Tags: , , — poster @ 9:35 pm

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced the introduction of Nicardipine Hydrochloride Injection, 2.5 mg/mL, which is AP-rated to EKR Therapeutics’ hypertension treatment Cardene® I.V. Teva’s product is the first alternative to the brand product, which had annual sales of approximately $181 million in the United States for the twelve months ended June 30, 2008, (more…)

« Older PostsNewer Posts »

Powered by WordPress